

AbCellera Information
Summary
AbCellera is a public company that has been in the industry for 13 years. The company currently specializes in the Biotechnology, Biotechnology areas. The position of the CEO is occupied by Carl Hansen. Its headquarters is located at Vancouver, British Columbia, CA. The number of employees ranges from 100 to 250. The annual revenue of AbCellera varies between 5.0M and 25M. Total funding of the company - $849M. To connect with AbCellera employee register on SignalHire.
Industries
Biotechnology
Headquarters Location
Employees Size
500-1000 employees
Specialties
Antibody Discovery, Cell Culture, Antibody Therapies, Protein Analysis, Microfluidic Single Cell Analysis, Single Cell Genomics, Monoclonal Antibody Discovery, Cell Enrichment, Cell Screening, Cell Recovery, Protein engineering, T cell engagers, Bispecifics
SIC Code
8000
Founded
2012
Estimated Annual Revenue
$5.0M - 25M
Operating Status
Independent Company
Competitors
Founded | Type | Employees | Revenue | Funding | |
---|---|---|---|---|---|
2018 | Privately Held | 1 - 25 | 6M | $109.5M | |
2013 | Public Company | 25 - 100 | 16.6M | $191M | |
2019 | Privately Held | 25 - 100 | 1.7M | $148M | |
2003 | Privately Held | 25 - 100 | < 1M | $69.2M | |
2004 | Public Company | 100 - 250 | 6.5M | $610M | |
2012 | Public Company | 25 - 100 | 5.2M | $409.9M | |
2013 | - | 100-200 | - | $- | |
2012 | - | 100-200 | - | $- | |
2008 | - | 500-1000 | - | $- |